$AIMT Morning .. couple things: 1. Hope you heeded my warning on AIMT approval drop .. check posts .. same as ACAD AMRN EPZN etc.. 2. For any "new approval" commercialization challenges are: a. Takes awhile for insurance companies to cover and communicate b. Company goes from research to hiring salespeople.. different business c. Hedgies made their money and exit position.. monitor 13Fs to see clearly With that said I'll nibble around $25 but stock could head to $20 with political arrows on drugs. Good luck.